PMHS (Polomar Health Services) YoY EBITDA Growth: 172.73% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PMHS Polomar Health Services Inc PMHS
37 GF Score
Price $0.30
GF Value $23.32
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Polomar Health Services YoY EBITDA Growth?

Polomar Health Services PMHS 37 YoY EBITDA Growth is 172.73% as of Jun. 2026. GuruFocus rates PMHS with a GF Score™ of 37/100 and a GF Value™ of $23.32 (Possible Value Trap). The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Polomar Health Services's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 172.73%.

Polomar Health Services's EBITDA per Share for the three months ended in Jun. 2026 was $0.01.

Polomar Health Services YoY EBITDA Growth Related Terms

Polomar Health Services YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Polomar Health Services's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polomar Health Services YoY EBITDA Growth Chart

Polomar Health Services Annual Data
Trend Dec07 Dec08 Dec09 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial 41.19 99.82 -450.00 -68.18 24.32

Polomar Health Services Quarterly Data
Mar10 Jun10 Sep10 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.14 -44.44 112.50 100.00 172.73
PMHS
37GF Score
Polomar Health Services Inc PMHS
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polomar Health Services YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Polomar Health Services's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.028--0.037)/ | -0.037 |
=24.32 %

Polomar Health Services's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.008--0.011)/ | -0.011 |
=172.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 172.73% mean?
Polomar Health Services (PMHS) has a YoY EBITDA Growth of 172.73% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Polomar Health Services and its competitors.
Is Polomar Health Services' YoY EBITDA Growth too high?
Polomar Health Services' current YoY EBITDA Growth is 172.73%. Overall, Polomar Health Services has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' YoY EBITDA Growth compare to DHTI and RDGT?
Polomar Health Services' YoY EBITDA Growth of 172.73% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Polomar Health Services and its competitors. Polomar Health Services's current YoY EBITDA Growth is 172.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $23.32, compared to a current price of $0.30 — trading 98.7% below its estimated fair value. The current YoY EBITDA Growth is 172.73%. Polomar Health Services' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current YoY EBITDA Growth is 172.73% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polomar Health Services (PMHS) Overvalued in 2026?

Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued. The current stock price of $0.30 is trading 98.7% below its estimated GF Value™ of $23.32. GuruFocus considers Polomar Health Services to be Possible Value Trap.

Key valuation signals for PMHS:

  • YoY EBITDA Growth: 172.73%
  • GF Value™: $23.32 vs. price of $0.30 (98.7% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polomar Health Services Business Description

Address 32866 US Highway, 19 N, Los Angeles, FL, USA, 34684
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
37GF Score

Get the complete analysis for PMHS

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30
Price
$23.32
GF Value